Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening

doi:10.3748/wjg.v23.i15.2743

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6924)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

536

WORD

510

HTML

2753

Tables (1-3)

164

Sum=3963

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1029

Download

1932

Sum=2961

Apr 21, 2017 (publication date) through Jul 5, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 21, 2017; 23(15): 2743-2749
Published online Apr 21, 2017. doi: 10.3748/wjg.v23.i15.2743

Table 2 Clinicopathologic findings of esophageal cancers detected in this study

Size (mm), median (range)	12.5 (5-60)
Depth¹
Tis/T1a/T1b	12/15/5
Location
Ce/Ut/Mt/Lt/Mt-Lt/Ae	0/1/20/8/2/1
Macroscopic type
0-IIc/0-IIc + IIa/0-I + IIb	30/1/1
Histopathological type
SCC/ adenocarcinoma	31/1
Treatment², endoscopic treatment/ surgery/chemoradiotherapy/ radiation/unknown	28/1/3/1/1
Lymph node metastasis
Positive/negative	1/31
Distant metastasis
Positive/negative	0/32

¹The depth of four lesions that were not resected (n = 3) or had an unknown treatment result (n = 1) were determined clinically: T1a (n = 2) and T1b (n = 2);

²Two cases overlapped: surgery following noncurative endoscopic resection (n = 1) and chemoradiotherapy following noncurative endoscopic resection (n = 1). Ae: Abdominal esophagus; Ce: Cervical esophagus; Lt: Lower thoracic esophagus; Mt: Middle thoracic esophagus; SCC: Squamous cell carcinoma; Ut: Upper thoracic esophagus.

Citation: Sekiguchi M, Terauchi T, Kakugawa Y, Shimada N, Saito Y, Matsuda T. Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening. World J Gastroenterol 2017; 23(15): 2743-2749
URL: https://www.wjgnet.com/1007-9327/full/v23/i15/2743.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i15.2743